Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Financials | 13.92% |
| 3 | Healthcare | 13.77% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Telkom Indonesia
TLK
$14.6B
| $10.8M | ﹤0.01% |
378,794
-545
| -0.1% | -$15.8K |
|
|
BMCH
1927
DELISTED
BMC Stock Holdings, Inc
BMCH
| $10.8M | ﹤0.01% |
376,154
-65,164
| -15% | -$1.83M |
|
|
BRY
1928
DELISTED
Berry Corp
BRY
| $10.8M | ﹤0.01% |
1,143,572
+306,550
| +37% | +$2.87M |
|
1929
Genesco
GCO
$391M
| $10.8M | ﹤0.01% |
224,998
-32,463
| -13% | -$1.35M |
|
|
NFBK
1930
DELISTED
Northfield Bancorp
NFBK
| $10.8M | ﹤0.01% |
635,164
+11,336
| +2% | +$190K |
|
|
NAV
1931
DELISTED
Navistar International
NAV
| $10.8M | ﹤0.01% |
371,979
+47,593
| +15% | +$1.46M |
|
1932
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
| $10.8M | ﹤0.01% |
37,744
+4,295
| +13% | +$1.18M |
|
1933
Southern Copper
SCCO
$156B
| $10.8M | ﹤0.01% |
276,493
-1,223
| -0.4% | -$42.1K |
|
1934
Bausch Health
BHC
$2.43B
| $10.8M | ﹤0.01% |
359,454
-10,404
| -3% | -$270K |
|
|
S
1935
DELISTED
Sprint Corporation
S
| $10.7M | ﹤0.01% |
2,057,491
-144,413
| -7% | -$846K |
|
1936
Park National Corp
PRK
$3.75B
| $10.7M | ﹤0.01% |
104,657
-4,653
| -4% | -$465K |
|
1937
ArcBest
ARCB
$3.19B
| $10.7M | ﹤0.01% |
387,173
+8,616
| +2% | +$249K |
|
|
ONC
1938
BeOne Medicines Ltd
ONC
$39.3B
| $10.7M | ﹤0.01% |
64,403
-2,250
| -3% | -$374K |
|
1939
Enova International
ENVA
$6.61B
| $10.7M | ﹤0.01% |
442,935
-10,676
| -2% | -$240K |
|
1940
Palomar
PLMR
$3.37B
| $10.7M | ﹤0.01% |
210,994
+16,453
| +8% | +$771K |
|
1941
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.48B
| $10.6M | ﹤0.01% |
110,000
-1,150
| -1% | -$106K |
|
1942
Hanmi Financial
HAFC
$962M
| $10.6M | ﹤0.01% |
528,712
+17,207
| +3% | +$332K |
|
1943
CBIZ
CBZ
$2.96B
| $10.5M | ﹤0.01% |
391,149
-15,760
| -4% | -$410K |
|
1944
Talos Energy
TALO
$2.63B
| $10.5M | ﹤0.01% |
348,402
+251,825
| +261% | +$5.88M |
|
1945
AtriCure
ATRC
$2.25B
| $10.5M | ﹤0.01% |
322,206
+8,681
| +3% | +$247K |
|
|
DBD
1946
DELISTED
Diebold Nixdorf Incorporated
DBD
| $10.5M | ﹤0.01% |
991,378
-9,402
| -0.9% | -$83.5K |
|
1947
Perdoceo Education
PRDO
$2B
| $10.4M | ﹤0.01% |
567,341
-265,409
| -32% | -$4.32M |
|
1948
Vanguard High Dividend Yield ETF
VYM
$84B
| $10.4M | ﹤0.01% |
111,087
-2,442
| -2% | -$221K |
|
1949
Element Solutions
ESI
$9.46B
| $10.4M | ﹤0.01% |
889,506
-102,024
| -10% | -$1.13M |
|
1950
Agios Pharmaceuticals
AGIO
$2B
| $10.4M | ﹤0.01% |
217,410
+19,306
| +10% | +$730K |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.